HN1L/AP-2γ/PLK1 signaling drives tumor progression and chemotherapy resistance in esophageal squamous cell carcinoma

Tingting Zeng(Nanchang University), Lei Li(Xinxiang Central Hospital)

Cell Death and Disease

December 7, 2022

10.1038/s41419-022-05478-1

Cited by 16

Related Papers

P38/NF-κB/Snail Pathway Is Involved in Caffeic Acid-Induced Inhibition of Cancer Stem Cells-Like Properties and Migratory Capacity in Malignant Human Keratinocyte

|PLoS ONE|2013|83

CD54-NOTCH1 axis controls tumor initiation and cancer stem cell functions in human prostate cancer

|Theranostics|2016|74

Expansion of cancer stem cell pool initiates lung cancer recurrence before angiogenesis

|Proceedings of the National Academy of Sciences|2018|53

TROAP switches DYRK1 activity to drive hepatocellular carcinoma progression

|Cell Death and Disease|2021|38

Hypoxia restrains the expression of complement component 9 in tumor-associated macrophages promoting non-small cell lung cancer progression

|Cell Death Discovery|2018|32